Hasil Pencarian - Dagmar Wider

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Intratibial injection of human multiple myeloma cells in NOD/SCID IL-2Rγ(null) mice mimics human myeloma and serves as a valuable tool for the development of anticancer strategies.

    Intratibial injection of human multiple myeloma cells in NOD/SCID IL-2Rγ(null) mice mimics human myeloma and serves as a valuable tool for the development of anticancer strategies.... oleh Julia Schueler, Dagmar Wider, Kerstin Klingner, Gabrielle M Siegers, Annette M May, Ralph Wäsch, Heinz-Herbert Fiebig, Monika Engelhardt

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Validated single-tube multiparameter flow cytometry approach for the assessment of minimal residual disease in multiple myeloma

    Validated single-tube multiparameter flow cytometry approach for the assessment of minimal residual disease in multiple myeloma oleh Sandra Maria Dold, Veronika Riebl, Dagmar Wider, Marie Follo, Milena Pantic, Gabriele Ihorst, Justus Duyster, Robert Zeiser, Ralph Wäsch, Monika Engelhardt

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Ten Color Multiparameter Flow Cytometry in Bone Marrow and Apheresis Products for Assessment and Outcome Prediction in Multiple Myeloma Patients

    Ten Color Multiparameter Flow Cytometry in Bone Marrow and Apheresis Products for Assessment and Outcome Prediction in Multiple Myeloma Patients oleh Veronika Riebl, Sandra Maria Dold, Sandra Maria Dold, Dagmar Wider, Marie Follo, Gabriele Ihorst, Johannes M. Waldschmidt, Johannes Jung, Michael Rassner, Michael Rassner, Christine Greil, Ralph Wäsch, Ralph Wäsch, Monika Engelhardt, Monika Engelhardt

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma)

    Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly,... oleh Johannes M. Waldschmidt, Alexander Keller, Gabriele Ihorst, Olga Grishina, Stefan Müller, Dagmar Wider, Anna V. Frey, Kristina King, Roman Simon, Annette May, Pierfrancesco Tassone, Justus Duyster, Manfred Jung, Noopur Raje, Ralph Wäsch, Monika Engelhardt

    Diterbitkan 2018-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: